StockDuty ← Dashboard Jul 20, 2026 02:34 AM ET
SignalKorea

SAMSUNG BIOLOGICS TO ACQUIRE SWISS-BASED CDMO FIRM FOR 2.7 TLN WON - YONHAP

Major acquisition of Swiss CDMO for 2.7 trillion won signals significant industry consolidation.

What changed
Why it matters
Major acquisition of Swiss CDMO for 2.7 trillion won signals significant industry consolidation.
Sources
yonhap
Related signals
SK HYNIX HOLDS GROUNDBREAKING CEREMONY FOR HBM PRODUCTION BASE IN US - KOREAHERALD →MEET SK HYNIX, THE TRILLION-DOLLAR SOUTH KOREAN CHIPMAKER DEBUTING ON U.S. MARKETS - CNBC →SOUTH KOREA TO HOLD EMERGENCY MARKET MEETING AFTER KOSPI TURMOIL - BLOOMBERG - GNEWS →